These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 30551846)
1. Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence. Dendle C; Mulley WR; Holdsworth S Transplant Rev (Orlando); 2019 Apr; 33(2):87-98. PubMed ID: 30551846 [TBL] [Abstract][Full Text] [Related]
2. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196 [TBL] [Abstract][Full Text] [Related]
4. Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. Pérez-Flores I; Sánchez-Fructuoso A; Santiago JL; Fernández-Arquero M; Calvo N; de la Concha EG; Barrientos A Transplant Proc; 2009; 41(6):2106-8. PubMed ID: 19715845 [TBL] [Abstract][Full Text] [Related]
5. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy. Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E; Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364 [TBL] [Abstract][Full Text] [Related]
6. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients. Wang XZ; Jin ZK; Tian XH; Xue WJ; Tian PX; Ding XM; Zheng J; Li Y; Jing X; Luo ZZ Transpl Immunol; 2014 Jan; 30(1):18-23. PubMed ID: 24211610 [TBL] [Abstract][Full Text] [Related]
7. A simple score can identify kidney transplant recipients at high risk of severe infection over the following 2 years. Dendle C; Polkinghorne KR; Mulley WR; Gan PY; Kanellis J; Stuart RL; Thursky K; Holdsworth SR Transpl Infect Dis; 2019 Jun; 21(3):e13076. PubMed ID: 30875147 [TBL] [Abstract][Full Text] [Related]
8. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P; Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Wieneke H; Otte B; Lang D; Heidenreich S Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection. van Gent R; Metselaar HJ; Kwekkeboom J Transplant Rev (Orlando); 2017 Apr; 31(2):78-86. PubMed ID: 28131494 [TBL] [Abstract][Full Text] [Related]